Latest News in Pharma industry

4 days ago

Amgen Reports First Survival Benefit in Global Phase 3 Trial for Relapsed Small Cell Lung Cancer

5 days ago

FDA Begins Phasing Out Animal Testing for Drug Safety Using AI Models and Human Organoids

6 days ago

Trump Announces Sweeping Tariffs on Imported Pharmaceuticals Triggering Market Selloff and Industry Backlash

6 days ago

Ireland Emerges as Europe's Most Vulnerable Economy in US-EU Tariff War

8 days ago

DHL Commits €2 Billion to Expand Global Healthcare Logistics Network by 2030

8 days ago

Genetic Test Validated to Predict Long-Term Side Effects of Radiation in Prostate Cancer Patients

12 days ago

BeiGene Retreats from Anti-TIGIT Bet, Exposing Industry-Wide Fault Lines in Immuno-Oncology

13 days ago

Why Genentech's 'Disappointing' MS Trial Outcome Might Be Its Most Reassuring Result Yet

13 days ago

Pfizer Faces Shareholder Backlash as Proxy Firm Opposes CEO’s $33 Million Pay Amid Revenue and Stock Decline

15 days ago

Chinese AI Biotech Sector Faces Downturn as Another Startup Struggles

16 days ago

Lilly’s Lepodisiran Cuts Genetic Heart Risk Factor by 94 Percent in Phase 2 Trial with Effects Lasting 1.5 Years

18 days ago

VRON-0200 Shows Promising Immune Response and Safety in Early Human Trial for Chronic Hepatitis B

18 days ago

Kobayashi Pharmaceutical Replaces President and Board Amid Health Crisis and Investor Pressure

18 days ago

Betting Big on Obesity - Inside Novo Nordisk’s $3 Billion Weekly M&A Gamble to Reinvent Weight Loss Treatment

20 days ago

Moderna Stock Drops Amid US Decision to Cut $2.6 Billion Vaccine Funding to Gavi

25 days ago

AstraZeneca’s Eneboparatide Meets Phase 3 Goals in Hypoparathyroidism Trial with Full Data Pending

26 days ago

Sanofi Acquires Dren Bio’s DR-0201 for $1.9 Billion to Advance Autoimmune Therapies

26 days ago

BioCopy Secures €8M to Accelerate AI-Powered Cancer Drug Discovery

28 days ago

bioMérieux Secures FDA Clearance for VITEK COMPACT PRO, Advancing Rapid Microbial Diagnostics

28 days ago

Maxion Therapeutics Secures $72M Series A to Advance KnotBody Antibody Drugs for Autoimmune and Pain Treatment

28 days ago

Google Unveils TxGemma AI to Accelerate Drug Discovery with Open Models

31 days ago

ELAHERE Improves Survival in Platinum-Resistant Ovarian Cancer AbbVie Releases Final Phase 3 Data

32 days ago

Sanofi Adopts FDA-Approved Flu Strains for 2025-26 Season to Ensure Vaccine Readiness

34 days ago

Trump Confronts Irish Prime Minister Over US Trade Deficit and Pharma Industry Shift

35 days ago

Geron CEO John Scarlett Steps Down as Biotech Firm Shifts Focus to Commercial Growth

36 days ago

Novartis Expands Radiopharmaceutical Investments with $10 Billion Growth Target

37 days ago

Medtronic’s SMART Trial Shows Evolut TAVR Outperforms SAPIEN in Small Aortic Annulus Patients

38 days ago

Bristol Myers Squibb's Sotyktu Shows Strong Phase 3 Results in Psoriatic Arthritis Trial, Eyes Regulatory Approval

38 days ago

Amgen and Kyowa Kirin Report Positive Phase 3 Results for Rocatinlimab in Atopic Dermatitis

39 days ago

Full Circles Therapeutics Secures Key Patent for Non-Viral Genome Editing with Circular DNA

41 days ago

FDA Approves Neffy Needle-Free Epinephrine Spray for Children with Severe Allergies

42 days ago

Needle-Free Vaccine Patch Delivers Stronger Immunity and a Path to the Future

43 days ago

Pharma’s Silent Purge: Are Veteran Scientists Being Replaced for Cheaper Talent?

44 days ago

Lexicon Pharmaceuticals Unveils Trial Results That Could Shake Up the $5 Billion Neuropathic Pain Market

44 days ago

Phase III Study Shows Xolair Outperforms Oral Immunotherapy with Fewer Side Effects in Food Allergy Treatment

47 days ago

Avobis Bio Moves Closer to Breakthrough Treatment for Crohn’s Fistulas with FDA Fast Track Approval

47 days ago

GSK Plans $27 Million CEO Pay Raise While Shares Drop 13 Percent Investors Face a High-Stakes Gamble

48 days ago

The Measles Resurgence: Two Deaths and Counting—Public Health Crisis and Market Implications

48 days ago

Enodia Therapeutics Secures Pfizer’s Golden Ticket With Game-Changing Protein Degradation Tech That Outshines PROTACs

48 days ago

Eli Lilly’s $50 Billion Gamble on U.S. Manufacturing Sparks Cheers, Fears, and Fierce Debate

49 days ago

Ecopipam’s Phase 3 Breakthrough Paves the Way for a New Era in Tourette Syndrome Treatment

50 days ago

Scientific Censorship Wipes Out Critical Data, Pharma Innovation at Risk as U.S. Faces Research Exodus

50 days ago

Hims & Hers Projects $2.3 Billion Revenue Amid Telehealth Growth and Regulatory Uncertainty

52 days ago

Trump’s Upcoming Pharma Tariff Shockwave Disrupts Global Supply Chains and Threatens Drug Prices

53 days ago

Novo Nordisk Ends Wegovy and Ozempic Shortage Sparks a $150 Billion GLP-1 Market Showdown with Eli Lilly

54 days ago

mRNA Vaccine Aftershocks Shake Pharma as Scientists Uncover Persistent Spike Protein and Investor Uncertainty Grows

54 days ago

Variational AI Scores $5.5M to Disrupt Drug Discovery with Generative AI, Challenging Industry Giants

54 days ago

Pfizer Ends Beqvez Development as Gene Therapy Faces Market Reality

55 days ago

Solid Biosciences Stock Skyrockets as Gene Therapy Breakthrough Sparks Investor Frenzy

56 days ago

VIVOZON Secures MFDS Approval for UNAFRA Inj a Game Changer in Non Opioid Pain Relief